NextGen Omics US

In-Person Conference

Registrations are closed

The NextGen Omics US brings together leading omics experts from around the world.

Delegates can expect to benefit from discussions in the future of Next Generation Sequencing, Multi-omic Single Cell Analysis and Genome editing in Drug Discovery and Therapeutic Development.

Attend our talk

Wednesday, March 30, 09:20 - 09:50 am (EDT)

CRISPR cell line development revolutionized:
Combining the power of CRISPR with FluidFM® to provide engineered cell lines as a service

Sensitive cells? Complex edits? High quality needed? We create the cell line for you.

Cytosurge provides you guaranteed monoclonal cell lines with high quality – even for hard-to-transfect and rare cells, complex edits like knock-in with large repair templates, or multiple knock-outs. 

During the presentation of Dr. Tobias Beyer, our Chief Scientific Officer, you will learn more about our service enabled by our proprietary FluidFM® technology:

  • What is FluidFM and how can it be applied to cell line engineering

  • True single cell genome engineering: the power of the bottom-up approach

  • High quality monoclonal cell lines by reducing off-target editing and avoiding the tedious selection process

  • Customized design and consulting by our experts

  • Recent customer projects

Dr. Tobias Beyer, Chief Scientific Officer at Cytosurge

Visit the NextGen Omics US event website

Date & Time
Tuesday March 29, 2022
Start - 2:20 AM (US/Eastern)
Wednesday March 30, 2022
End - 9:45 AM (US/Eastern)

Hyatt Regency Boston

One Avenue de Lafayette
Boston MA 02111
United States
--Hyatt Regency Boston--
+1 617 912 1234
Get the direction

Oxford Global Marketing Ltd

+44 1865 248455

Find out what people see and say about this event, and join the conversation.